Gene PlCaMK1 and application thereof in preventing and treating peronophythora litchii
By identifying PlCaMK1, a pathogenic protein related to Phytie Cream, and knocking out its genes using CRISPR/Cas9 technology, the pathogenicity of Phytie Cream, solving the problem of prevention and treatment of lychee Cream, providing new drug targets and theories Based on this, the pathogenic mechanism of Phytophthora lychee cream has been deeply revealed.
Patent Information
- Application Number
- CN202411162828.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-23
AI Technical Summary
The prevention and treatment of lychee cream disease has not been effectively solved in the prior art, and the pathogenic mechanism of Phytophthora lychee cream is unknown, and there is a lack of effective disease-resistant lychee planting varieties and low-toxic fungicides.
By identifying and publishing the pathogenic protein PlCaMK1 and its encoding genes of Phytophthora lychee Cream, the PlCaMK1 knockout vector was constructed using CRISPR/Cas9 gene editing technology, and knocking out the PlCaMK1 gene through PEG-mediated protoplast transformation technology, and reducing pathogenicity was achieved mutants of the disease, and their application in the prevention and treatment of litchi cream.
It is confirmed that the gene PlCaMK1 is necessary for the pathogenicity of Phytophthora lychee cream. The knockout mutant of PlCaMK1 has significantly reduced the pathogenicity of Phytophthora lychee cream, providing a new target for the development of low-toxic and safe anti-lychee cream. Phytophthora drugs provide theoretical basis and deeply clarify the pathogenic molecular mechanism of Phytophthora lychee cream.
Smart Images

Figure CN119020316A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of green prevention and control of crop diseases, and particularly relates to a gene PlCaMK1 and an application thereof in preventing and controlling litchi downy mildew. Background Art
[0002] The disease caused by the infection of Peronophythora litchii (Peronophythora litchii Chen ex Ko et al.) is litchi downy blight, and its host plant is litchi. The pathogen belongs to the subphylum Mastigomycetes, class Oomycetes, order Peronosporales, and family Peronophthoraceae. The litchi downy blight caused by Peronophythora litchii is the most serious on litchi, and no effective disease-resistant litchi planting variety has been found. At present, the prevention and control of litchi downy blight is still mainly based on pesticide control, which has a high risk of drug resistance and pollutes the environment. Therefore, it is of great significance to study the pathogenic mechanism of litchi downy blight.
[0003] Studies have shown that the successful infection of litchi by litchi downy mildew mainly depends on a series of pathogenic factors. Therefore, fully exploring litchi pathogenicity-related genes and conducting functional studies are of great significance for effectively controlling the damage of litchi downy mildew and breeding disease-resistant varieties. CaMKI is a monomeric enzyme with broad substrate specificity that can phosphorylate many different proteins. In oomycetes, there are few reports on Ca2+ / calmodulin kinase. Homologous proteins of CaMK1 have been identified in palm phytophthora (Phytophthorapalmivora) and pepper phytophthora (P. capsici). After pepper phytophthora was treated with the fungicide-cinnamaldehyde acid, the expression of CAMK / CAMK1 protein kinase was downregulated, which changed the hyphae morphology of pepper phytophthora and disrupted the polysaccharide metabolism of the fungus. Summary of the invention
[0004] In view of the defects or shortcomings in the prior art, the primary purpose of the present invention is to provide a litchi downy mildew pathogenicity-related protein PlCaMK1.
[0005] Another object of the present invention is to provide biological materials related to the above-mentioned litchi downy mildew pathogenicity-related protein PlCaMK1.
[0006] Another object of the present invention is to provide the application of the above-mentioned litchi downy mildew pathogenicity-related protein PlCaMK1 or biomaterial.
[0007] In order to achieve the above-mentioned object of the invention, the present invention adopts the following technical solutions:
[0008] The present invention discloses a previously unknown protein PlCaMK1 of litchi downy mildew and its encoding gene PlCaMK1. The full length of the gene PlCaMK1 is shown in SEQ ID NO.1, and its CDS sequence is shown in SEQ ID NO.2, encoding a total of 747 amino acids, as shown in SEQ ID NO.3. The present invention utilizes CRISPR / Cas9 gene editing technology to construct pBSSK::PlCaMK1 and PYF2.3G-ribo-sgRNA1::PlCaMK1 and PYF2.3G-ribo-sgRNA2::PlCaMK1 knockout vectors and knocks out the PlCaMK1 gene through PEG-mediated protoplast transformation technology. Finally, knockout mutants T4, T22, and T40 (named according to the sequence number of transformant verification) were obtained, and the three mutants had obvious defects in the pathogenic process of litchi downy mildew. The results of pathogenicity determination showed that the knockout mutants T4, T22, and T40 of the gene PlCaMK1 significantly reduced the pathogenicity to young leaves of litchi (variety: Guiwei). The above experiments proved that the PlCaMK1 gene of litchi downy mildew is a pathogenicity-related gene of litchi downy mildew.
[0009] A litchi downy mildew pathogenicity-related protein PlCaMK1, whose amino acid sequence is shown in SEQ ID NO.3, or a similar sequence obtained by replacing, inserting or deleting one or more amino acids in SEQ ID NO.3 and still having the same or similar function.
[0010] The above-mentioned biological material related to the litchi downy mildew pathogenicity-related protein PlCaMK1 is any one or more combinations of the following biological materials:
[0011] 1) a nucleic acid molecule encoding the litchi downy mildew pathogenicity-related protein PlCaMK1;
[0012] 2) an expression cassette containing the nucleic acid molecule described in 1);
[0013] 3) A recombinant vector containing the nucleic acid molecule described in 1), or a recombinant vector containing the expression cassette described in 2);
[0014] 4) a recombinant microorganism containing the nucleic acid molecule described in 1), or a recombinant microorganism containing the expression cassette described in 2), or a recombinant microorganism containing the recombinant vector described in 3);
[0015] 5) a nucleic acid molecule that inhibits or blocks the gene expression of the litchi downy mildew pathogenicity-related protein PlCaMK1;
[0016] 6) A gene knockout vector for inhibiting or blocking the gene expression of the litchi downy mildew pathogenicity-related protein PlCaMK1 prepared by using the nucleic acid molecule described in 5);
[0017] 7) A litchi downy mildew-deficient protein PlYPK1 related to litchi downy mildew prepared by using the gene knockout vector described in 6).
[0018] Furthermore, the nucleic acid molecule in 1) is the gene sequence of the litchi downy mildew pathogenicity-associated protein PlCaMK1, as shown in SEQ ID NO: 1, or the CDS sequence of the litchi downy mildew pathogenicity-associated protein PlCaMK1, as shown in SEQ ID NO: 2, or a similar sequence having the same or similar function obtained by base insertion, deletion, or substitution as shown in SEQ ID NO. 1 or SEQ ID NO: 2.
[0019] Furthermore, the nucleic acid molecule in 5) is antisense RNA, siRNA, shRNA or sgRNA of the PlCaMK1 gene.
[0020] Furthermore, the sgRNA is represented by any of the following sequences:
[0021] sgRNA1: 5'-CACTACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTAGTGTCTCTGGAGATCTC-3';
[0022] sgRNA2: 5'-TAGAACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTTCTAGCGCTTGTGGGTTA-3'.
[0023] The application of the above-mentioned litchi downy mildew pathogenicity-related protein PlCaMK1 or biomaterial is any one or more combinations of the following applications:
[0024] i) Application in regulating the pathogenicity of litchi downy mildew;
[0025] ii) Application in regulating the infection ability of litchi downy mildew;
[0026] iii) Application in regulating the motility of zoospores of Lychee Downy Phytophthora;
[0027] iv) Application in regulating zoospore formation of Lychee Downy Phytophthora;
[0028] ⅴ) Application in regulating the germination of spores of Lychee Downy Phytophthora;
[0029] ⅵ) Application in the prevention and treatment of litchi frost blight;
[0030] ⅶ) Application as a target in the design and screening of drugs against litchi downy mildew.
[0031] A method for preventing and controlling litchi downy blight caused by litchi downy blight is achieved by inhibiting or blocking the gene expression of the litchi downy blight pathogenicity-related protein PlCaMK1.
[0032] A drug screening model against litchi downy mildew, wherein the drug screening model is a litchi downy mildew gene-deficient protein PlCaMK1 associated with litchi downy mildew pathogenicity.
[0033] The method for constructing the above-mentioned anti-litchi downy mildew drug screening model comprises the following steps:
[0034] (1) Design sgRNA according to the PlCaMK1 gene sequence using the sgRNA website, connect the sgRNA with the pYF2.3G-Rib o-sgRNA vector to obtain the PlCaMK1 gene knockout plasmid pYF2.3G-Ribo-sgRNA::PlCaMK1;
[0035] Alternatively, left and right homology arm amplification primers were designed based on the upstream and downstream sequences of about 1 kb of the PlCaMK1 gene sequence, and the left and right homology arms were amplified using the genomic DNA of Peronophythora litchii as a template, and ligated with the pBSSK vector to obtain the PlCaMK1 gene knockout plasmid pBSSK::PlCaMK1.
[0036] (2) The PlCaMK1 gene knockout plasmid pYF2.3G-Ribo-sgRNA::PlCaMK1 or pBSSK::PlCaMK1 was introduced into the protoplasts of the wild-type strain of litchi downy mildew, and after screening and verification, the PlCaMK1 gene knockout mutant was obtained, which is the litchi downy mildew drug screening model.
[0037] Furthermore, the sgRNA described in step (1) is any of the following sequences:
[0038] sgRNA1: 5'-CACTACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTAGTGTCTCTGGAGATCTC-3';
[0039] sgRNA2: 5'-TAGAACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTTCTAGCGCTTGTGGGTTA-3'.
[0040] Furthermore, the left and right homology arm amplification primers described in step (1) are as follows:
[0041] Left homology arm amplification primer:
[0042] PlCaMK1-Left-F: 5'-CTAGAACTAGTGGATCCCCCTGTCGTAACGCAAAGGAAGT-3';
[0043] PlCaMK1-Left-R: 5'-GTATAATACAACAAACAGATTTTAGTGGAAACTTGCTCGA-3';
[0044] Right homology arm amplification primers:
[0045] PlCaMK1-Right-F: 5'-TCGAGCAAGTTTCCACTAAAATCTGTTTTGTTGTATTATAC-3';
[0046] PlCaMK1-Right-R: 5'-ATATCGAATTCCTGCAGCCCTTCGTTAGTTCCTTACTTTC-3'.
[0047] Compared with the prior art, the present invention has the following advantages and effects:
[0048] The present invention proves through experiments that the upstream and downstream sequences of the gene PlCaMK1 are amplified respectively, connected to the vector pBSSK (kindly donated by the Oomycete and Fungal Molecular Biology Laboratory of the College of Plant Protection of Nanjing Agricultural University), and after homologous recombination, the obtained mutants are transformed by protoplast transformation technology mediated by Polyethylene glycol (PEG) and CRISPR / Cas9 knockout strategy. Compared with the wild type, there is no significant difference in growth rate, sporangium and oospore production. The zoospore motility test shows that the deletion of the gene PlCaMK1 significantly reduces the motility of zoospores of litchi downy mildew. The present invention confirms that the gene PlCaMK1 is necessary for the pathogenicity of litchi downy mildew. Our research helps to further clarify the pathogenic molecular mechanism of litchi downy mildew, and provides a theoretical basis for discovering new drug action targets and designing new efficient, low-toxic and safe fungicides. BRIEF DESCRIPTION OF THE DRAWINGS
[0049] Figure 1 It is a schematic diagram of the construction of homologous recombination of the litchi downy mildew PlCaMK1 gene; wherein A is a schematic diagram of the construction of the pYF2.3G-Ribo-sgRNA::PlCaMK1 vector and the pBSSK::PlCaMK1 vector, B is a schematic diagram of the PlCaMK1 gene knockout design, and C is the sequencing result of the knockout mutant.
[0050] Figure 2It is a PCR amplification result diagram of litchi downy mildew PlCaMK1 gene knockout transformant; wherein, lane WT: litchi downy mildew wild type; lane CK: PEG-transformant but not knocked out; lanes T4, T22, and T40 respectively represent three knockout transformants of gene PlCaMK1; wherein: a is the PCR amplification result; b is the statistical result.
[0051] Figure 3 The growth rates and colony morphologies of the wild type WT, non-knockout transformant CK, knockout mutants T4, T22, and T40 on CA medium are shown in the figure; wherein: a is the colony morphology; b is the growth rate statistics.
[0052] Figure 4 The results of zoospore motility analysis of the gene PlCaMK1 knockout mutants T4, T22, and T40; wherein: a is the number changes of zoospores (Zoospores), cysts (Cysts), and germination cysts (GerminationCysts) of wild-type WT and Δplcamk1 at 10min, 20min, 40min, 1h, and 2h, and the scale bar in the figure is 200μm; b is the spore number statistics of the wild-type strain of litchi downy mildew at different times; c is the spore number statistics of the PlCaMK1 knockout mutant at different times.
[0053] Figure 5 It is a graph showing the results of pathogenicity analysis of gene PlCaMK1 knockout mutants; wherein: a is the diseased lesions of wild-type WT, CK and three PlCaMK1 mutants (T4, T22 and T40) directly dropped onto litchi leaves with zoospore suspension; b is the statistical lesion diameter of a; c is the diseased lesions of WT, CK and PlCaMK1 mutants that rely on zoospore motility to infect leaves; d is the statistical lesion diameter of c.
[0054] Figure 6 It is a graph showing the results of analysis of spore germination of knockout mutants of the gene PlCaMK1; wherein: a is the observation of suspensions of spore germination made from wild type WT, CK and three PlCaMK1 knockout mutants (T4, T22 and T40) under a microscope, the arrows are spores with germinated germ tubes, and the scale bar in the figure is 100 μm; b is the proportion of germination of spores per 100 in the spore germination suspension. DETAILED DESCRIPTION
[0055] The present invention is further described in detail below in conjunction with embodiments and drawings, but the embodiments of the present invention are not limited thereto.
[0056] If no specific experimental conditions are specified in the following embodiments, conventional experimental conditions or experimental conditions recommended by the reagent company are generally followed. The materials and reagents used, unless otherwise specified, are all reagents and materials obtained from commercial sources.
[0057] Example 1: Construction of PlCaMK1 gene knockout vector
[0058] Test materials
[0059] Test strains, plants and vectors:
[0060] The test strain is the wild type strain of litchi downy mildew (Peronophythora litchii, Wild Type, referred to as WT), which is a conventional phytophthora fungus that can be obtained through commercial channels or isolated from nature. The Eschrichia coli strain JM109 can be obtained through commercial channels. The plant material for inoculation is young leaves of litchi (Nuomici) (collected from the horticultural practice orchard of South China Agricultural University); the oomycete knockout and transformation vectors pYF2-PsNLS-hSpCas9, pYF2.3G-Ribo-sgRNA (disclosed in the literature "Yufeng, Fang, Linkai, et al. Efficient Genome Editing in the Oomycete Phytophthora sojae Using CRISPR / Cas9 [J]. Current Protocols in Microbiology, 2017"), and pBSSK (disclosed in the literature "ACRISPR / Cas9-mediated in situ complementation method for Phytophthora sojae mutants [J]. Molecular Plant Pathology, 2021, 22(3)”. The above vectors were kindly donated by the Laboratory of Oomycete and Fungal Molecular Biology, College of Plant Protection, Nanjing Agricultural University).
[0061] Main test culture medium:
[0062] Carrot agar (CA) (1 L): 300 g carrot juice was squeezed, filtered through gauze, and sterilized at 121° C. for 20 min. 1.5% (W / V) agar powder was added to the solid culture medium.
[0063] LB medium (1 L): 5 g yeast extract, 10 g tryptone, 10 g sodium chloride (NaCl), sterilized at 121° C. for 20 min. Add 1.5% (W / V) agar powder to the solid medium.
[0064] Nutrition Pea Broth (NPB) (1L): 120g fresh peas were boiled in water for 20min and filtered. 5g sorbitol (D-Sorbitol), 5g mannitol (D-Mannitol), 5g glucose, 3g potassium nitrate (KNO3), 2g calcium carbonate (CaCO3), 2g yeast extract, 1g potassium dihydrogen phosphate (K2HPO4) were added to the filtrate. 4) , 1g potassium dihydrogen phosphate (KH2PO4), 0.5g magnesium sulfate (MgSO4), 0.1g calcium chloride (CaCl2), 2mL vitamin stock and 2ml trace elements, add ddH2O to 1L, sterilize at 121℃ for 20min. For solid culture medium, add 1.5% (W / V) DifcoBacto Agar.
[0065] Pea mannitol medium (Pea / 0.5mol·L -1 Manitol, PM) (1L): 120g fresh peas, boiled in water for 20min, filtered. Add 91g D-Mannitol, 2g CaCO3 and 1.32g CaCl2 to the filtrate, add ddH2O to 1L, sterilize at 121℃ for 20min. For solid culture medium, add 1.5% (W / V) DifcoBacto Agar.
[0066] Petri medium (1L): 0.5g potassium dihydrogen phosphate, 0.25g magnesium sulfate heptahydrate (MgSO4·7H2O), 1g L-asparagine, 1mg vitamin B1, 0.5g yeast extract, 10mg β-sitosterol and 5g glucose, add ddH2O to 1L, sterilize at 121℃ for 20min. Add 1.5% agar powder to the solid medium.
[0067] Construction of CRISPR / Cas9 technology-related vectors:
[0068] (1) Construction of pYF2.3G-Ribo-sgRNA::PlCaMK1
[0069] According to the website for designing sgRNA (http: / / grna.ctegd.uga.edu / ), the targeting RNA (sgRNA) on the PlCaMK1 gene was selected and delivered to Sangon Biotech for synthesis. The sgRNA annealing system was prepared according to Table 1, and the metal bath was 37°C for 30 min.
[0070] The sgRNA sequences are as follows:
[0071] PlCaMK1-sgRNA1-F: 5'-CTAGCCACTACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTAGTGTCTCTGGAGATCTC-3'
[0072] PlCaMK1-sgRNA1-R: 5'-AAACGAGATCTCCAGAGACACTACGACGAGCTTACTCGTTTCGTCCTCACGGACTCATCAGGTAGTGG-3'
[0073] PlCaMK1-sgRNA2-F: 5'-CTAGCTAGAACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTTCTAGCGCTTGTGGGTTA-3'
[0074] PlCaMK1-sgRNA2-R: 5'-AAACTAACCCACAAGCGCTAGAACGACGAGCTTACTCGTTTCGTCCTCACGGACTCATCAGGTTCTAG-3'.
[0075] Table 1 sgRNA double-stranded synthesis system (30 μL) (Takara)
[0076]
[0077] The reaction conditions were 37°C for 30 min, and then 4 μL of 0.5 mol·L -1 NaCl, mix well and boil in a boiling water bath for 2 minutes, then cool at room temperature for 3 to 4 hours to allow the DNA fragments to anneal to form double strands.
[0078] The targeting RNA (sgRNA) on the PlCaMK1 gene was annealed to form a double strand, and then connected to the pYF2.3G-Ribo-sgRNA vector after restriction digestion (the restriction digestion system is shown in Table 2) using T4-DNA ligase. The connection system is shown in Table 3. The reaction conditions are 16°C, 12h, cooled on ice, and then transformed into Escherichia coli.
[0079] Table 2 pYF2.3G-Ribo-sgRNA vector double enzyme digestion system (50 μL) (NEB)
[0080]
[0081]
[0082] Table 3 pYF2.3G-Ribo-sgRNA vector and double-stranded sgRNA ligation reaction system (10 μL) (NEB)
[0083]
[0084] (2) Construction of pBSSK::PlCaMK1 vector
[0085] The left and right homology arms and amplification primers (PlCaMK1-Left-F, PlCaMK1-Left-R, PlCaMK1-Right-F, PlCaMK1-Right-R) were designed based on the sequences of about 1 kb upstream and downstream of the PlCaMK1 gene.
[0086] PlCaMK1-Left-F: 5'-CTAGAACTAGTGGATCCCCTCCAGTAACATATTGGTGGT-3'
[0087] PlCaMK1-Left-R: 5'-GTATAATACAACAAACAGATTTTAGTGGAAACTTGCTCGA-3'
[0088] PlCaMK1-Right-F:5'-TCGAGCAAGTTTCCACTAAAATCTGTTTTGTTGTATTATAC-3'
[0089] PlCaMK1-Right-R: 5'-ATATCGAATTCCTGCAGCCCTTCGTTAGTTCCTTACTTTC-3'.
[0090] PCR amplification was performed using high-fidelity enzyme Phanta Max Super-Fidelity DNA Polymerase (Nanjing Novozyme), and the left and right homologous arms were amplified using litchi Downy Phytophthora genomic DNA as a template. The specific PCR amplification system is shown in Table 4:
[0091] Table 4 Phanta Max high-fidelity enzyme PCR amplification system (50 μL)
[0092]
[0093] The amplification procedure was: pre-denaturation at 95°C for 3 min, denaturation at 95°C for 15 s, annealing at 56-72°C for 15 s, extension at 72°C for 30 s / kb, 34 cycles, and finally extension for 5 min. The target band was detected by electrophoresis and then recovered using the agarose gel purification recovery kit of OMEGA. For specific steps, refer to the instructions of the kit. After the product concentration was detected, the directional seamless cloning kit ClonExpress One Step Cloning Kit (Nanjing Novozyme) was used to connect with the linearized pBSSK vector (enzyme digestion system see Table 5), and the connection system is shown in Table 6.
[0094] Table 5 pBSSK restriction enzyme digestion reaction system (10 μL)
[0095]
[0096] Table 6 pBSSK::PlCaMK1 vector ligation reaction system (10 μL)
[0097]
[0098] The constructed pYF2.3G-Ribo-sgRNA1::PlCaMK1, pYF2.3G-Ribo-sgRNA2::PlCaMK1, and pBSSK::PlCaMK1 were transformed into Escherichia coli.
[0099] (3) E. coli transformation and verification
[0100] 100 μL of E. coli competent cells JM109 were frozen and thawed on ice, 10 μL of the ligation product was added, and the mixture was mixed by tapping with fingertips, and then placed on ice for 30 min. Heat shock was performed in a 42°C water bath for 90 s, and then quickly placed on ice for 2 min. 650 μL of LB liquid culture medium was added to the tube and cultured at 37°C, 180 rpm for 1 h. The above bacterial solution was centrifuged at 4000 rpm for 4 min, the supernatant was aspirated, and the remaining 100 μL of LB culture medium was used to suspend the bacteria and spread on a plate containing a final concentration of 100 μg mL -1 The Amp was cultured on LB solid screening plates at 37°C for 12 to 16 hours.
[0101] Using a single colony of Escherichia coli as a template, the verification primers for the pYF2.3G-Ribo-sgRNA vector were M13F and RPL41_Pse q_F; the verification primers for the pBSSK vector were M13F and M13R; among them, M13F and M13R were universal primers, and the sequence of primer RPL41_Pseq_F was as follows: RPL41_Pseq_F: 5'-CAAGCCTCACTTTCTGCTGACTG-3'.
[0102] Green Taq Mix (Nanjing Novozyme) was used for colony PCR verification, and the system is as shown in Table 7:
[0103] Table 7 Colony PCR reaction system (20 μL)
[0104]
[0105] The PCR amplification procedure was as follows: pre-denaturation at 94°C for 5 min, denaturation at 94°C for 30 s, annealing at 60°C for 30 s, extension at 72°C for 30 s / kb, 34 cycles, and extension for 7 min. The amplified products were detected by gel electrophoresis, and two colonies with amplified bands that matched the target fragment size were selected and stained with 100 μg mL -1 Amp was cultured in LB liquid medium and sent for sequencing.
[0106] (4) Large-scale extraction of plasmid DNA
[0107] Select a single colony of E. coli containing the target plasmid and shake it. Add the single colony to a solution containing 100 μg mL -1 The mixture was added to 200 mL of LB liquid medium containing Amp and cultured at 37°C, 180 rpm for 12 h. The mixture was added to 200 mL of LB liquid medium containing Amp and cultured at 37°C, 180 rpm for 14 h.
[0108] The four plasmids required for PEG-mediated transformation (pYF2-PsNLS-hSpCas9, pYF2.3G-Ribo-sgRNA1::PlCaMK1, pYF2.3G-Ribo-sgRNA2::PlCaMK1, and pBSSK::PlCaMK1) were extracted using TIANGEN's EndoFree Maxi Plasmid Kit.
[0109] Example 2: Preparation of protoplasts of Peronophytum litchii and PEG-mediated transformation
[0110] Preparation of enzymatic solution: weigh 0.15g Lysing Enzymes (SIGMA) and 0.06g Cellulase (SIGMA) in a sterile beaker, add 10mL 0.8mol·L -1 Mannitol, 8 mL sterile ddH2O, 800 μL 0.5 mol·L -1 KCl, 800 μL 0.5 mol·L -1 MES-KOH and 400 μL 0.5 mol·L -1 After CaCl2 is fully dissolved, transfer to a 50 mL centrifuge tube for later use;
[0111] Preparation of W5 solution: weigh 7.8 g Glucose, 4.6 g CaCl2, 2.25 g NaCl, 0.093 g KCl, add ddH2O to make up to 250 mL, and set aside;
[0112] Preparation of MMg solution: weigh 18.22 g of mannitol, 0.76 g of MgCl2·6H2O, and 2 mL of MES Buffer, add water to make up to 250 mL, and set aside;
[0113] The wild-type strain of Peronophytum litchii WT was activated on nutrient pea solid plate medium (NPB solid medium). The mycelium block was placed in a conical flask, and 50 mL of NPB liquid medium was added for cultivation. Three bottles were cultured in the dark at 25°C for 3 days, and shaken every 12 hours. The mycelium was collected by gauze filtration, gently squeezed with tweezers, and added to a 50 mL centrifuge tube containing enzymatic solution. After gently mixing, the enzymatic solution was hydrolyzed at 25°C and 40 rpm for 40 to 45 minutes. After the mycelium was hydrolyzed, the mycelium was quickly filtered with a 50 mL beaker wrapped with three layers of Miracloth filter cloth, and the filtrate was transferred to a 50 mL round-bottom centrifuge tube and centrifuged at 4°C and 1500 rpm for 3 minutes. The supernatant was discarded, 10 mL of W5 solution was added to resuspend the protoplasts, and then 25 mL of W5 solution was added, and the mixture was gently mixed upside down, and centrifuged at 4°C and 1500 rpm for 4 minutes. Discard the supernatant, add 7mL W5 solution to resuspend the protoplasts, and place on ice for 30min. Then centrifuge at 4℃, 1500rpm for 4min, discard the supernatant, add 6mL MMg solution to resuspend the protoplasts, and place in the greenhouse for 10min. Take 6 sterilized 50mL centrifuge tubes and place them on ice. Add 4 plasmids to each centrifuge tube: pYF2-PsNLS-hSpCas9, pYF2.3G-Ribo-sgRNA1::PlCaMK 1, pYF2.3G-Ribo-sgRNA2::PlCaMK1, pBSSK::PlCaMK1, 30μg each, to obtain MMg solution containing protoplasts.
[0114] Add 1 mL of MMg solution containing protoplasts to each 50 mL centrifuge tube, shake gently to mix, and place on ice for 10 min. Add 580 μL of 40% polyethylene glycol (PEG) solution to each centrifuge tube along the tube wall, and add three times in succession. During this process, slowly rotate the centrifuge tube to mix the PEG and protoplasts, and place on ice for 20 min. Add 100 mg mL PEG to pea mannitol culture medium (PM) at a dilution of 1000:1. -1Amp PM was prepared from ampicillin. Add 2 mL of Amp PM to a centrifuge tube, gently turn it upside down, and place it on ice for 2 min; continue to add 8 mL of Amp PM to the centrifuge tube, gently turn it upside down, and place it on ice for 2 min; finally, add 10 mL of Amp PM to each centrifuge tube in turn, gently turn it upside down, and place it at an angle. Incubate in the dark at 25°C for 14 to 16 hours to allow the protoplasts to regenerate. After overnight incubation, observe the regeneration of the protoplasts under a microscope, and then centrifuge at 2000 rpm for 5 min. Discard the supernatant from each centrifuge tube until 5 mL of liquid culture medium remains, suspend the precipitate, and add 30 mL of 30 μg·mL -1 Geneticin G418 pea mannitol solid medium, invert and mix, pour into two 9 cm sterile culture dishes, and culture in the dark at 25 ℃ for 2 to 3 days. Pick a single colony and number it for identification.
[0115] Example 3: Validation and determination
[0116] (1) Verification and analysis of PlCaMK1 gene knockout transformants
[0117] The genomic DNA of the wild type WT and transformants of Litchi Downy Phytophthora was extracted by CTAB method, and the genomic DNA was used as a template to design primers PlCaMK1BY-F and PlCaMK1BY-R outside the left and right homologous arm fragments of PlCaMK1 in the genome for conventional PCR amplification. The band size was detected by gel electrophoresis to verify whether PlCaMK1 was successfully knocked out and sent for sequencing detection.
[0118] PlCaMK1BY-F: 5'-CCATGAAAAAATTATCGGTTGGGTTAGACGA-3'
[0119] PlCaMK1BY-R: 5'-CGGTATTGAGTCATCATCATCAATCTAGTGG-3'.
[0120] The sequencing results proved that the PEG transformation knockout was successful, and 3 PlCaMK1 gene knockout transformants were obtained. They were numbered from T1 according to the transformant verification sequence. The 3 successfully knocked out mutants were named T4, T22, and T40, respectively.
[0121] (2) Determination of growth rate of knockout mutants
[0122] The wild-type WT strain of litchi downy mildew, the transformant CK that grew in a medium containing G418 antibiotics but failed to be knocked out, and the mutants T4, T22, and T40 that successfully knocked out the PlCaMK1 gene were transferred twice on CA plates without antibiotics. The 9mm diameter WT, CK, T4, T22, and T40 mycelial blocks of the same bacterial age were punched and inoculated in the center of a 15mL equal amount of carrot medium plate (diameter = 9cm). Set up 3 replicates, culture at 25℃ in the dark for 5d, measure the colony diameter, calculate the growth rate, and take pictures. The experiment was repeated three times independently, and the Duncan's multiple range test in SPSS software was used to analyze the significance of the differences between the strains.
[0123] Growth rate (mm / d) = colony diameter on day 5 / 5 days.
[0124] (3) Determination of zoospore motility of knockout mutants
[0125] Take the WT, CK and T4, T22, T40 mycelium blocks with the same age of 9 mm in diameter obtained by the transfer culture in the determination step (2) and inoculate, take 5 of each group and place them in a 10 mL centrifuge tube, add 2.5 mL ddH2O, and oscillate them with a vortex oscillator for 1 min to allow the sporangium to fully fall off the sporangium stalks to obtain a sporangium suspension. After the spore suspension is placed in a 4°C refrigerator for 30 min, it is placed at room temperature for 10 min, 20 min, 40 min, 1 h, and 2 h, and the zoospores on the surface of 1 μL of liquid are aspirated, and the number of zoospores in each microliter is counted. The data for each sample is counted 10 times, and the average value is taken for zoospore motility analysis.
[0126] (4) Determination of pathogenicity of knockout mutants
[0127] Take the WT, CK and T4, T22, T40 mycelium blocks of the same age obtained in the transfer culture in the determination step (2) and inoculate them. Take 5 of each group and place them in 2.5mL ddH2O. Use a vortex oscillator to shake for 1min to allow the sporangium to fully fall off the sporangium stalks to obtain a sporangium suspension. Place the sporangium suspension in a 16℃ incubator to allow the zoospores to be released. Count and dilute to 10 zoospores / μL under a microscope. Wash the young leaves of litchi (variety is Nuomici) with ddH2O and place them on a clean bench to dry. Inoculate each young leaf with 10μL of zoospore suspension. Repeat the inoculation of 6 young leaves of similar age for each strain. Keep the culture moist at 25℃. Take pictures after 48h and measure the diameter of the lesions. Use Duncan's multiple range test in SPSS software for significant difference analysis.
[0128] Young leaves of litchi (variety Nuomici) were soaked in ddH2O and placed on wet filter paper. The WT, CK and T4, T22, and T40 mycelium blocks with the same age of 9 mm obtained by the transfer culture in the determination step (2) were inoculated, and the mycelium growth surface was covered on the back of the leaf. Each strain was repeatedly inoculated with 6 young leaves of similar leaf age, placed at 25℃ to keep moist, and photographed after 48 hours and the diameter of the lesions was measured. Duncan's multiple range test in SPSS software was used for significant difference analysis.
[0129] (5) Determination of oospore production of knockout mutants
[0130] At the edge of the colonies of WT, CK, T4, T22, and T40 after two transfer cultures, a bacterial plate of the same size (d = 9 mm) was removed using a sterile cork puncher and transferred to the surface to cover a layer of Hybond N + After culturing in the dark at 25°C for 10 days on the carrot medium with membrane, the membrane was peeled off, 5 bacterial discs were randomly punched with a hole puncher near the inoculation point, and the plates were homogenized in 5 mL ddH2O. 1 μL was aspirated and placed on a slide to count the number of oospores of each strain.
[0131] (6) The zoospores obtained in (4) were filtered out using a nylon membrane with a pore size of 50 μm. The zoospores were vortexed to cause the flagella on the zoospores to fall off and form dormant spores. The zoospores were cultured at room temperature for 1 h. An appropriate amount of copper sulfate solution was then added to the suspension. 1 μL of the dormant spore suspension was aspirated and the number of dormant spores and germinated dormant spores was counted under a microscope. The data were counted 10 times for each sample and the average value was taken.
[0132] Example 4: Results and Analysis
[0133] (1) Construction of the recombinant fragment of the PlCaMK1 gene of Peronophytum litchii
[0134] The PlCaMK1 gene homology arm Left and homology arm Right fragments were cloned by PCR technology, and the multiple fragments were connected to the linearized pBSSK vector to successfully obtain the pBSSK::PlCaMK1 vector; sgRNA was obtained by double-stranded synthesis and connected to the linearized pYF2.3G-Ribo-sgRNA vector to successfully obtain pYF2.3G-Ribo-sgRNA1::PlCaMK1 and pYF2.3G-Ribo-sgRNA2::PlCaMK1 vectors. The knockout schematic is shown in Figure 1 .
[0135] (2) Screening of knockout mutants of the litchi downy mildew gene PlCaMK1
[0136] The primers for the left and right arms of the gene PlCaMK1 were designed: PlCaMK1BY-F / R, and DNA of the wild type (WT), non-knockout transformant (CK) and PlCaMK1 gene knockout mutant of litchi downy mildew were extracted. PCR amplification was performed with the wild type as the control. The amplification method and system were referred to Example 1. The results showed that WT and CK amplified fragments of about 5000 bp, and the three transformants T4, T22 and T40 could amplify fragments of about 2000 bp, further indicating that T4, T22 and T40 were knockout transformants of the gene PlCaMK1 ( Figure 2 ), and the sequencing results confirmed that it had indeed been knocked out. The sequencing results of T4, T22, and T40 are as follows:
[0137]
[0138] (3) Analysis of growth rate of PlCaMK1 knockout mutant
[0139] Compared with the wild type WT and the non-knockout transformant CK, the growth rate of the knockout mutants T4, T22, and T40 in CA medium was basically the same as that of WT, and the mycelial color was no different from that of the wild type ( Figure 3 ).
[0140] (4) Analysis of zoospore motility of PlCaMK1 knockout mutant
[0141] After low-temperature induction of the wild-type WT, more zoospores were released from the top layer of the sporangium suspension at room temperature for 10 minutes, the number of zoospores reached the highest at 20 minutes, and the number of zoospores was basically the same from 40 minutes to 2 hours. A small number of zoospores turned into resting spores from 40 minutes to 1 hour, and a small number of zoospores turned into resting spores and germinated at 2 hours. After low-temperature induction of the PlCaMK1 mutant, more zoospores were released from the top layer of the sporangium suspension at 10 minutes, a large number of zoospores were released at 20 minutes, a large number of zoospores turned into resting spores at 40 minutes, and almost all of them turned into resting spores and partially germinated at 1 hour, and almost all of the resting spores germinated at 2 hours. After swimming for 5.5 hours at room temperature, the zoospores of the litchi downy mildew WT almost all turned into resting spores, that is, the swimming time of the zoospores of the PlCaMK1 knockout mutant was nearly 5 hours shorter than that of the WT. It can be seen that the knockout of PlCaMK1 significantly damaged the motility of the zoospores ( Figure 4 ).
[0142] (5) Pathogenicity analysis of PlCaMK1 knockout mutants
[0143] Compared with the wild-type WT and the non-knockout transformant CK, the zoospore suspensions of the knockout mutants T4, T22, and T40 were directly inoculated on litchi leaves. The pathogenicity of the PlCaMK1 knockout mutants to litchi leaves was basically the same as that of WT and CK. Using the motility of the zoospores to infect litchi leaves resulted in a significantly lower pathogenicity of the PlCaMK1 knockout mutants than that of WT and CK ( Figure 5 ).
[0144] (6) Analysis of spore germination in knockout mutants of the gene PlCaMK1
[0145] Zoospore suspensions of wild-type strains WT, CK, and three PlCaMK1 knockout mutants (T4, T22, and T40) were prepared and placed in a room at 28°C for 2 h. It was observed that the apnospore germination rate of the PlCaMK1 knockout mutants was slightly higher than that of WT and CK ( Figure 6 ).
[0146] The experimental results show that the gene provided by the present invention can be used for plant disease prevention and control, especially litchi downy blight caused by litchi downy blight. In addition, the gene provided by the present invention can be used as a drug target for plant disease prevention and control. Those skilled in the art can develop drugs for preventing and controlling plant diseases, especially litchi downy blight, according to the guidance and inspiration of this specification.
[0147] The above examples are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above examples. Any other changes, modifications, substitutions, combinations, and simplifications made without departing from the spirit and principles of the present invention shall be equivalent alternatives and shall be included in the protection scope of the present invention.
Claims
1. A litchi downy mildew pathogenicity-related protein PlCaMK1, characterized in that: Its amino acid sequence is shown in SEQ ID NO.3, or is a similar sequence obtained by replacing, inserting or deleting one or more amino acids as SEQ ID NO.3 and still having the same or similar function.
2. The biomaterial related to the litchi downy mildew pathogenicity-related protein PlCaMK1 as claimed in claim 1, characterized in that: Any one or more combinations of the following biological materials: 1) a nucleic acid molecule encoding the litchi downy mildew pathogenicity-related protein PlCaMK1; 2) an expression cassette containing the nucleic acid molecule described in 1); 3) A recombinant vector containing the nucleic acid molecule described in 1), or a recombinant vector containing the expression cassette described in 2); 4) a recombinant microorganism containing the nucleic acid molecule described in 1), or a recombinant microorganism containing the expression cassette described in 2), or a recombinant microorganism containing the recombinant vector described in 3); 5) a nucleic acid molecule that inhibits or blocks the gene expression of the litchi downy mildew pathogenicity-related protein PlCaMK1; 6) A gene knockout vector for inhibiting or blocking the gene expression of the litchi downy mildew pathogenicity-related protein PlCaMK1 prepared by using the nucleic acid molecule described in 5); 7) A litchi downy mildew-deficient protein PlCaMK1 of litchi downy mildew pathogenicity-related protein prepared by using the gene knockout vector described in 6).
3. The biomaterial according to claim 2, characterized in that: 1) The nucleic acid molecule is the gene sequence of the litchi downy mildew pathogenicity-related protein PlCaMK1, as shown in SEQ ID NO: 1, or the CDS sequence of the litchi downy mildew pathogenicity-related protein PlCaMK1, as shown in SEQ ID NO: 2, or a similar sequence having the same or similar function obtained by base insertion, deletion, or substitution as shown in SEQ ID NO. 1 or SEQ ID NO: 2; 5) The nucleic acid molecule is antisense RNA, siRNA, shRNA or sgRNA of the PlCaMK1 gene.
4. The biomaterial according to claim 3, characterized in that: The sgRNA is shown in any of the following sequences: sgRNA1: 5'-CACTACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTAGTGTCTCTGGAGATCTC-3'; sgRNA2: 5'-TAGAACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTTCTAGCGCTTGTGGGTTA-3'.
5. Use of the litchi downy mildew pathogenicity-associated protein PlCaMK1 as claimed in claim 1 or the biomaterial as claimed in any one of claims 2 to 4, characterized in that: Any one or more combinations of the following applications: i) Application in regulating the pathogenicity of litchi downy mildew; ii) Application in regulating the infection ability of litchi downy mildew; iii) Application in regulating the motility of zoospores of Lychee Downy Phytophthora; iv) Application in regulating zoospore formation of Lychee Downy Phytophthora; ⅴ) Application in regulating the germination of spores of Lychee Downy Phytophthora; ⅵ) Application in the prevention and treatment of litchi frost blight; ⅶ) Application as a target in the design and screening of drugs against litchi downy mildew.
6. A method for preventing and controlling litchi downy blight caused by litchi downy blight, characterized in that: This is achieved by inhibiting or blocking the gene expression of the litchi downy mildew pathogenicity-related protein PlCaMK1 described in claim 1.
7. A drug screening model for resistance to litchi downy mildew, characterized in that: The drug screening model is a litchi downy mildew gene defective type of litchi downy mildew pathogenicity-related protein PlCaMK1 described in claim 1.
8. The method for constructing a drug screening model against litchi downy mildew as claimed in claim 7, characterized in that: The steps include: (1) Design sgRNA according to the PlCaMK1 gene sequence using the sgRNA website, connect the sgRNA with the pYF2.3G-Rib o-sgRNA vector to obtain the PlCaMK1 gene knockout plasmid pYF2.3G-Ribo-sgRNA::PlCaMK1; Alternatively, left and right homology arm amplification primers were designed based on the sequences of about 1 kb upstream and downstream of the PlCaMK1 gene sequence, and the left and right homology arms were amplified using the genomic DNA of Peronophythora litchii as a template, and connected with the pBSSK vector to obtain the PlCaMK1 gene knockout plasmid pBSSK::PlCaMK1; (2) The PlCaMK1 gene knockout plasmid pYF2.3G-Ribo-sgRNA::PlCaMK1 or pBSSK::PlCaMK1 was introduced into the protoplasts of the wild-type strain of litchi downy mildew, and after screening and verification, the PlCaMK1 gene knockout mutant was obtained, which is the litchi downy mildew drug screening model.
9. The method for constructing a screening model for drugs against litchi downy mildew according to claim 8, characterized in that: The sgRNA described in step (1) is any of the following sequences: sgRNA1: 5'-CACTACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTAGTGTCTCTGGAGATCTC-3'; sgRNA2: 5'-TAGAACCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCGTTCTAGCGCTTGTGGGTTA-3'.
10. The method for constructing a screening model for drugs against litchi downy mildew according to claim 8, characterized in that: The left and right homology arm amplification primers described in step (1) are as follows: Left homology arm amplification primer: PlCaMK1-Left-F: 5'-CTAGAACTAGTGGATCCCCCTGTCGTAACGCAAAGGAAGT-3'; PlCaMK1-Left-R: 5'-GTATAATACAACAAACAGATTTTAGTGGAAACTTGCTCGA-3'; Right homology arm amplification primers: PlCaMK1-Right-F: 5'-TCGAGCAAGTTTCCACTAAAATCTGTTTTGTTGTATTATAC-3'; PlCaMK1-Right-R: 5'-ATATCGAATTCCTGCAGCCCTTCGTTAGTTCCTTACTTTC-3'.
Citation Information
Patent Citations
Gene PlYPK1 and application thereof in preventing and treating litchi downy blight
CN115820596A
Fused heterocycle structure-containing compound, preparation method therefor and applications thereof, and fungicide
WO2020034992A1
